NCEP guidelines which classify CVD risk on the basis of LDL-C level, are helpful in targeting individuals at risk early in life.

Elevated serum low-density lipoprotein-cholesterol(LDL-C)is a major risk factor for cardiovascular diseases.

血清低密度脂蛋白-胆固醇（LDL-C）升高是心血管疾病的一个重要危险因素。

Multivariate analysis revealed that the drop in LDL-C and increase in HDL-C both independently predicted atheroma regression.

多变量分析显示LDL-C水平的降低以及HDL-C水平的增加各自都能改善动脉粥样硬化。

However, stating, despite producing marked reductions in LDL-C, are not associated with an increased risk of cancer.

然而，仅管他汀类药物能显著减低低密度脂蛋白，但它与癌症发生率的增高并无内在联系。

Of the patients that had low LDL-C concentrations, normal triglyceride and HDL-C levels, 14 percent had an elevated LDL particle number.

参与研究的病人有低低密度脂蛋白胆固醇水平，正常的甘油三酯和高密度脂蛋白胆固醇水平，有14%的患者低密度脂蛋白粒子数升高。

Probucol did not change serum levl of TG, but the serum levels of TC and LDL-C were significantly lowered.

普罗布考对甘油三酯无明显影响，但是血清总胆固醇及低密度脂蛋白胆固醇均明显降低。

Danshen yin could decrease the level of TC and LDL-c in serum ( P & lt; 0.05 ).

丹参饮亦能降低血清TC、LDL-c的含量 ( P & lt; 0.05 ).

Conclusions: Very low LDL-C and normal SBP are associated with the slowest progression of coronary atherosclerosis.

结论: 非常低水平的LDL -C 和正常SBP与较慢的冠状动脉粥样硬化进展相关.

There was a postive correlation between plasma FFA and hsCRP.

血浆FFA与 hsCRP水平呈正相关;(3)血浆FFA、hsCRP、 TG、 LDL-c 水平与大血管病变呈正相关.

For patients whose LDL C reductions were above the median value.

低密度脂蛋白胆固醇降低高于中间值的病人.

That serum HDL-C was significantly lower but LDL-C has no change in patients with ⅳ type hyperlipemia;

Ⅳ型高脂血症患者HDL-C明显降低，LDL-C无明显变化；

Analysis of tc, tg, HDL-C and LDL-C in elderly diabetes patients with CHD

老年糖尿病合并冠心病患者血浆胆固醇、甘油三酯及高、低密度脂蛋白分析

The concentrations of TG and HDL-C are no difference in all groups ( P0.05).

血清TG和HDL-C浓度在各组无显著差异性（P0.05）。

Results The hemorrheology indexes and the levels of total cholesterol ( TC), triglyceride ( TG), low-density lipoprotein cholesterol ( LDL-C) and very low density lipoprotein cholesterol ( VLDL-C) in ACI group were significantly higher than those in healthy control group ( P0.05 or P0.01).

结果ACI患者血液流变学参数均较健康老年组高（P0.01）；血甘油三酯、总胆固醇、低密度脂蛋白胆固醇、极低密度脂蛋白胆固醇均较健康老年组高（P0.05或P0.01）。

Results Compared to the normal control group, the total cholesterol ( TC) and very low density lipoprotein cholesterol ( vLDL-C) in the CHD group were higher ( p0.01), and the high density lipoprotein cholesterol ( HDL-C) was lower ( P0.01);

结果CHD患者血清中的总胆固醇（TC）和极低密度脂蛋白胆固醇（vLDL-C）均较正常对照组高（P0.01）；高密度脂蛋白胆固醇（HDL-C）较正常对照组低（P0.01）；

Da Huai Mixture was more effective than alcoholic extract of Da Huang in ( 1) reducing TC, VLDL-C, and LDL-C levels and ( 2) stimulating bile acid excretion in rats with experimental hypercholesterolemia.

实验结果表明，大槐合剂降低实验性高胆固醇血症大鼠血清TC、VLDL-C和LDL-C水平以及促进胆汁酸的排泌作用均强于单独应用大黄醇提取物。

Comparison of the indexes of blood lipids: In the treatment group, the triglyceride, cholesterol, LDL-C and VLDL-C after treatment were all decreased as compared with those before treatment, and HDL-C was higher than that before treatment.

血脂各项指标比较：治疗组治疗后的三酰甘油、胆固醇、低密度脂蛋白-胆固醇、极低密度脂蛋白-胆固醇均比治疗前降低，高密度脂蛋白-胆固醇高于治疗前；

EEP and WSP could modulate the metabolize of lipid in DM, decreased the level of TC, TG, LDL-C, VLDL-C and increased the level of HDL-C.

蜂胶能调节糖尿病大鼠体内脂质代谢，降低总胆固醇、甘油三酯、低密度脂蛋白胆固醇、极低密度脂蛋白胆固醇水平，升高高密度脂蛋白胆固醇水平。

Metformin hydrochloride decreased the content of triglyceride, cholesterol and VLDL-C in serums, the content of triglyceride and cholesterol in the liver and the content of cholesterol in Egg.

降低了肝脏中胆固醇和甘油三酯的含量；降低了鸡蛋中胆固醇的含量。

The number of fat drops in liver had significantly positive correlation with TC, TG and LDL-c, however, negative correlation with VLDL-c, and positive correlation with HDL-c, but no significance.

脂肪肝的病变程度与TC、TG、LDL-C呈显著正相关，与VLDL-C呈显著负相关，与HDL-C呈正相关，但无显著性。

The levels of T-CHOL, TG, LDL-C and VLDL-C in serum of rats were detected to observe the preventive and therapeutical effects of Yinqu Capsule.

采用预防和治疗给药，通过测定大鼠血清中总胆固醇、甘油三酯等水平，观察银曲胶囊对实验性大鼠血脂的影响。